Contenuto
Ti trovi in: HOME »Programmi, progetti e risultati »I progetti »PRIN - Programmi di ricerca di Rilevante Interesse Nazionale»Programma di ricercaINIZIO_TESTO_DA_INDICIZZARE
RESEARCH PROGRAM
italiano - inglese
Research Units
- Università degli Studi di FIRENZE
FIRENZE(FI) - Università degli Studi di CAMERINO
BIOLOGIA MOLECOLARE, CELLULARE E ANIMALE
CAMERINO(MC) - Università degli Studi di CATANIA
SCIENZE CHIMICHE
CATANIA(CT) - Università degli Studi di FIRENZE
FARMACOLOGIA PRECLINICA E CLINICA "M. AIAZZI MANCINI"
FIRENZE(FI) - Università degli Studi di BRESCIA
SCIENZE BIOMEDICHE E BIOTECNOLOGIE
BRESCIA(BS)
Similar research programs:
- 1 - RELATIONSHIP BETWEEN MEMBRANE IONIC PERMEABILITY AND INTRACELLULAR RED-OX STATE DURING NEURODEGENERATIVE PROCESS: ACTION OF AMYLOID PEPTIDES IN NEURONAL AND GLIAL CELLS.
- 2 - Genetic and molecular determinants of the role of COX-2 in atherothrombosis.
- 3 - Role of metals – Ubiquitin/Proteasome interaction in the pathogenesis of conformational diseases
- 4 - Molecular features of protein conformational diseases. Role of environmental factors on the structural changes of proteins for the design and the synthesis of agents with antiaggregating, antioxidant, antiglycating and chelating activity and for application in diagnostics.
- 5 - CELL SIGNALING PATHWAYS, REACTIVE OXYGEN SPECIES (ROS) AND REACTIVE NITROGEN SPECIES (RNS): ROLE IN CELL AGING AND TUMOR GROWTH.
- 6 - AMYLOID PRECURSOR PROTEINS AS A NEW FAMILY OF MOLECULAR SWITCHES CONTROLLING CELL FUNCTION: A LESSON DERIVED FROM THE STUDY OF ALZHEIMER'S DISEASE.
- 7 - Mechanisms of injury and protection in the ischemic heart
- 8 - BETA AMYLOID THE CULPRIT OF ALZHEIMER’S NEURODEGENERATION OR A NEW PLAYER IN BRAIN PHYSIOLOGICAL AND PATHOLOGICAL NEUROMODULATION?
- 9 - BETA-AMYLOID PRODUCTION AND CLEARANCE IN PATIENTS WITH ALZHEIMER DISEASE AND MILD COGNITIVE IMPAIRMENT: IN VITRO STUDIES AND EX VIVO MARKERS
- 10 - Endocannabinoid system as potential modulator of neurodegeneration in an animal model of Alzheimer's Disease.
Scientific and education field classification
- Field: Scienze biologiche
International Patent Classification
- CHEMISTRY; METALLURGY
- BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
- ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
- PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Geographical classification
- Region: Toscana
Keywords
ALZHEIMER'S DISEASE; BETA AMYLOID PEPTIDES; CALCIUM; OXIDATIVE STRESS; APOPTOSIS PATHWAYS; PROTEASOME; TRASCRIPTION FACTORS; FIBRILLOGENESIS INHIBITORS; TRANSGENIC MICEMolecular bases of cytotoxicity by distinct beta-amyloid specific misfolding/aggregation states: a comprehensive investigation in vitro, in cultured cells and in animal model
Università degli Studi di FirenzeAbstract
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by three main structural changes in the brain: diffuse loss of neurons in the hippocampus and neocortex, accumulation of intracellular protein deposits termed neurofibrillary tangles and extracellular formation of senile plaques. The amyloid core of senile plaques consists of deposits of β-amyloid (Aβ) protein. The hypofunction of cholinergic neurons in the cortex and hippocampus contributes significantly to the cognitive symptoms associated with AD. Unknown is still the mechanism behind neurodegeneration and the "amyloid cascade" hypothesis has defined the fibrillation of Aβ into amyloid plaques as the primary culprit in the neurotoxicity. According to this hypothesis, Aβ undergoes, over a period of time, conformational changes concomitant with self assembly into oligomers, profibrils, fibrils until they are deposited in senile plaques. Despite the large number of researches on this issue, whether or not this is an unbreakable and irreversible process and the biological role of the different Aβ aggregation states remain to be established. A central role of oxidative stress in AD pathogenesis has been suggested and Aβ combination with the brain's intrinsic supply of Cu2+, Zn2+ and Fe2+ mediates the peptide's aggregation and toxicity, through hydrogen peroxide production. In AD, the oxidation injury is mediated by the generation of hydrogen peroxide and the scavenging defences >>>Principal Investigator
Gianfranco LIGURI Università degli Studi di FIRENZEResearch Objectives
This proposal aims to clarify the molecular bases of neuronal death upon exposure to misfolded and aggregated Abeta species by experiments carried out in vitro, in cultured cells and in an animal model. Structural, molecular and biological basis of Abeta aggregate formation and toxicity to cultured cells and the differential susceptibility to toxicity will be studied on cultured human neuroblastoma cells and Alzheimier's fibroblasts. In particular we will investigate specific intracellular pathways occurring during a neurodegenerative process where free radical production has been demonstrated to be the major contributor. Furthermore we will test antioxidant compounds (such as glutathione esters and thioesters) and compounds endowed with the property to interfere with Abeta fibrillogenesis (i.e. clioquinol) on Abeta-induced neurotoxicity. The main goal of this project is to answer the following questions: 1) how the different Abeta; aggregation states affect neuronal cell function; 2) are free radicals and calcium homeostasis involved in the conformation-specific Abeta toxicity; 3) which signal transduction and apoptosis pathways are affected, and 4) is it possible to identify molecules able to reinforce the cellular defences against Abeta toxicity or to shift the equilibrium between the different Abeta aggregation states so as to reduce deleterious vs not-deleterious Abeta species?In particular, the following tasks will be pursued:
1 >>>



